This is a working overview of vaccine adjuvant, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-11. Anything still debated is marked as such rather than presented as settled.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 3,108 Da | Consistent with a 28-residue acetylated peptide |
| Residue count | 28 | Corresponds to the amino terminal region of prothymosin alpha |
| Appearance of dry powder | White to off-white solid | Slight variation between lots is normal |
| Solubility class | Freely soluble in water | Low solubility in most organic solvents |
| Common synonyms | Thymosin alpha 1, T alpha 1 | The numeral reflects an early fraction numbering scheme |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
binding site A region of a macromolecule such as a nucleic acid or a protein that directly participates in chemical interactions with another molecule. A wide variety of chemical interactions of varying strength and specificity can be described as "binding"; they may be long-term or transient, reversible or irreversible, and may rely upon relatively weak intermolecular forces or much stronger covalent bonds. Binding sites are defined by the spatial proximity of one or more residues having functional groups with particular chemical properties. For example, the folding of polypeptides in such a way that particular amino acids are positioned near each other in the protein's quaternary structure may confer chemical properties that permit the interaction of those residues with a particular ligand. Similarly, a specific sequence of nucleobases in a DNA molecule may function as a recognition site for a DNA-binding protein. Whether and how the binding site functions depends on the precise spatial arrangement of the interacting residues and their physical accessibility to potential binding partners; thus mutations or changes in the chemical environment such as conformational changes can dramatically alter functionality. See also active site.
== Historiography of Knoxville == The East Tennessee Historical Society's annual journal, published since 1929, contains numerous articles on Knoxville and Knoxville-area topics. The Society has also published two comprehensive histories of Knoxville and Knox County, The French Broad-Holston Country (1946), edited by Mary Utopia Rothrock, and Heart of the Valley (1976), edited by Lucile Deaderick. In 1982, the Society published a follow-up to Heart of the Valley, William MacArthur's Knoxville: Crossroads of the New South, which includes hundreds of historic photographs. Other comprehensive histories of the city include William Rule's Standard History of Knoxville (1900) and Ed Hooper's Knoxville (2003), the latter being part of Arcadia's "Images of America" series. The Civil War is one of the most extensively covered periods of Knoxville's history. Two early first-hand accounts of the war in Knoxville are William G. Brownlow's Sketches of the Rise, Progress and Decline of Secession (1862) and the diary of Ellen Renshaw House, edited by Daniel Sutherland and published as A Very Violent Rebel: The Civil War Diary of Ellen Renshaw House (1996). First-hand accounts written after the war include William Rule's The Loyalists of Tennessee in the Late War (1887), Thomas Williams Humes's The Loyal Mountaineers of Tennessee (1888), Oliver Perry Temple's East Tennessee and the Civil War (1899), and Albert Chavannes's East Tennessee Sketches (1900).
=== Toning === Toners help balance the skin's pH and are typically used after cleansing but prior to moisturizing. They can have a number of benefits, depending on their formula and should be chosen to suit an individuals skin needs, such as reducing pores (using toners that have salicylic acid) for oily and acne skin types, brightening complexion (with toners that have vitamin C), soothing inflammation (via toners with ingredients such as aloe vera) for sensitive skin types or using toners that include retinol for aging skin, which can help to improve fine lines.
Swiss Chalet is a Toronto-based restaurant chain known primarily for their rotisserie chicken. To date Swiss Chalet operates in every province but British Columbia, Saskatchewan and Quebec. Sometimes you can find a Swiss Chalet and Harvey's combo location.
Belize was granted independence on 21 September 1981. Guatemala refused to recognize the new nation because of its longstanding territorial dispute, claiming that Belize belonged to Guatemala. After independence about 1,500 British troops remained in Belize to deter any possible Guatemalan incursions. With George Cadle Price at the helm, the PUP won all national elections until 1984. In that election, the first national election after independence, the PUP was defeated by the United Democratic Party (UDP). UDP leader Manuel Esquivel replaced Price as prime minister, with Price himself unexpectedly losing his own House seat to a UDP challenger. The PUP under Price returned to power after elections in 1989. The following year the United Kingdom announced that it would end its military involvement in Belize, and the RAF Harrier detachment was withdrawn the same year, having remained stationed in the country continuously since its deployment had become permanent there in 1980. British soldiers were withdrawn in 1994, but the United Kingdom left behind a military training unit to assist with the newly created Belize Defence Force. The UDP regained power in the 1993 national election, and Esquivel became prime minister for a second time. Soon afterwards, Esquivel announced the suspension of a pact reached with Guatemala during Price's tenure, claiming Price had made too many concessions to gain Guatemalan recognition. The pact may have curtailed the 130-year-old border dispute between the two countries.
Sources: en.wikipedia.org
== Modern scientific uses == Though insects were widely used throughout history for medical treatment on nearly every continent, relatively little medical entomological research has been conducted since the revolutionary advent of antibiotics. Heavy reliance on antibiotics, coupled with discomfort with insects in Western culture limited the field of insect pharmacology until the rise of antibiotic resistant infections sparked pharmaceutical research to explore new resources. Arthropods represent a rich and largely unexplored source of new medicinal compounds.
== Mechanism of action == Nicotinamide adenine dinucleotide (NAD), along with its phosphorylated variant nicotinamide adenine dinucleotide phosphate (NADP), are utilized in transfer reactions within DNA repair and calcium mobilization. NAD also plays a critical role in human metabolism, acting as a coenzyme in both glycolysis and the Krebs cycle.
Agarose is a preferred matrix for work with proteins and nucleic acids as it has a broad range of physical, chemical and thermal stability, and its lower degree of chemical complexity also makes it less likely to interact with biomolecules. Agarose is most commonly used as the medium for analytical scale electrophoretic separation in agarose gel electrophoresis. Gels made from purified agarose have a relatively large pore size, making them useful for separation of large molecules, such as proteins and protein complexes >200 kilodaltons, as well as DNA fragments >100 basepairs. Agarose is also used widely for a number of other applications, for example immunodiffusion and immunoelectrophoresis, as the agarose fibers can function as anchor for immunocomplexes.
Dubnium, having an atomic number of 105, is a superheavy element; like all elements with such high atomic numbers, it is very unstable. The longest-lasting known isotope of dubnium, 268Db, has a half-life of around a day. No stable isotopes have been seen, and a 2012 calculation by JINR suggested that the half-lives of all dubnium isotopes would not significantly exceed a day. Dubnium can only be obtained by artificial production. The short half-life of dubnium limits experimentation. This is exacerbated by the fact that the most stable isotopes are the hardest to synthesize. Elements with a lower atomic number have stable isotopes with a lower neutron–proton ratio than those with higher atomic number, meaning that the target and beam nuclei that could be employed to create the superheavy element have fewer neutrons than needed to form these most stable isotopes. (Different techniques based on rapid neutron capture and transfer reactions are being considered as of the 2010s, but those based on the collision of a large and small nucleus still dominate research in the area.) Only a few atoms of 268Db can be produced in each experiment, and thus the measured lifetimes vary significantly during the process. As of 2022, following additional experiments performed at the JINR's Superheavy Element Factory (which started operations in 2019), the half-life of 268Db is measured to be 16+6−4 hours. The second most stable isotope, 270Db, has been produced in even smaller quantities: three atoms in total, with lifetimes of 33.4 h, 1.3 h, and 1.6 h.
Sources: en.wikipedia.org
MDMA is a well-balanced serotonin–norepinephrine–dopamine releasing agent (SNDRA). (R)-MDMA and (S)-MDMA are both SNDRAs similarly. However, (R)-MDMA is several-fold less potent than (S)-MDMA in vitro and is also less potent than (S)-MDMA in vivo in non-human primates. In addition, whereas MDMA and (S)-MDMA are well-balanced SNDRAs, (R)-MDMA is comparatively much less potent as a dopamine releasing agent (~11-fold less potent in releasing dopamine than serotonin), and could be thought of instead more as a serotonin–norepinephrine releasing agent (SNRA) than as an SNDRA. In non-human primates, (S)-MDMA demonstrated significant dopamine transporter (DAT) occupancy, whereas DAT occupancy with (R)-MDMA was undetectable. Similarly, MDMA and (S)-MDMA were found to increase dopamine levels in the striatum in rodents and non-human primates, whereas (R)-MDMA did not increase striatal dopamine levels. As such, (R)-MDMA may be less psychostimulant-like than MDMA or (S)-MDMA. In addition to its actions as an SNDRA, MDMA has weak affinity for the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors, where it acts as an agonist. (R)-MDMA shows higher affinity for the serotonin 5-HT2A receptor than (S)-MDMA or MDMA. In addition, (R)-MDMA is more potent as an agonist of the serotonin 5-HT2A receptor, acting as a weak partial agonist of this receptor, whereas (S)-MDMA shows very little effect. Conversely however, (S)-MDMA is more potent as an agonist of the serotonin 5-HT2C receptor. Based on these findings, it has been hypothesized that (R)-MDMA may be more psychedelic-like than (S)-MDMA.
An expression vector must have elements necessary for gene expression. These may include a promoter, the correct translation initiation sequence such as a ribosomal binding site and start codon, a termination codon, and a transcription termination sequence. There are differences in the machinery for protein synthesis between prokaryotes and eukaryotes, therefore the expression vectors must have the elements for expression that are appropriate for the chosen host. For example, prokaryotes expression vectors would have a Shine-Dalgarno sequence at its translation initiation site for the binding of ribosomes, while eukaryotes expression vectors would contain the Kozak consensus sequence. The promoter initiates the transcription and is therefore the point of control for the expression of the cloned gene. The promoters used in expression vector are normally inducible, meaning that protein synthesis is only initiated when required by the introduction of an inducer such as IPTG. Gene expression however may also be constitutive (i.e. protein is constantly expressed) in some expression vectors. Low level of constitutive protein synthesis may occur even in expression vectors with tightly controlled promoters.
== Metabolism == Stercobilin results from breakdown of the heme moiety of hemoglobin found in erythrocytes (red blood cells). Macrophages break down senescent erythrocytes and break the heme down into biliverdin, which rapidly reduces to free bilirubin. Bilirubin binds tightly to plasma proteins (especially albumin) in the blood stream and is transported to the liver, where it is conjugated with one or two glucuronic acid residues into bilirubin diglucuronide, and secreted into the small intestine as bile. In the small intestine, some bilirubin glucuronide is converted back to bilirubin via bacterial enzymes in the terminal ileum. This bilirubin is further converted to colorless urobilinogen by the bacterial enzyme bilirubin reductase. Urobilinogen that remains in the colon can either be reduced to stercobilinogen and finally oxidized to stercobilin, or it can be directly reduced to stercobilin. Stercobilin is responsible for the brown color of human feces. Stercobilin is then excreted in the feces.
They generate revenue by extorting pre-existing producers, and illegally establish their own farms with help from corrupt federal officials. Similar market manipulations have taken place in the tortilla, lime, and chicken markets. As opposed to the Sinaloa Cartel, which operates by inserting their authority into entire vertical supply chains, the CJNG generally taxes across the market, taxing a wide variety of businesses at the same level of the value chain. Pemex, the nationalized Mexican oil company, has lost hundreds of millions of dollars to fuel theft, to which the CJNG, as well as several other Mexican organized crime groups have been linked. Illegally drilled pipelines extract fuel which is then sold for exaggerated rent on the black market. Individuals, as well as several Mexican companies, have been sanctioned for their complicity in timeshare fraud with the CJNG, whereby third-party scammers rob timeshare owners of their money by entering into a fictitious deal and demanding premature taxes and fees to 'expedite' the sales process.
This may account for the curious fact that proline is usually solvent-exposed, despite having a completely aliphatic side chain. Multiple prolines and/or hydroxyprolines in a row can create a polyproline helix, the predominant secondary structure in collagen. The hydroxylation of proline by prolyl hydroxylase (or other additions of electron-withdrawing substituents such as fluorine) increases the conformational stability of collagen significantly. Hence, the hydroxylation of proline is a critical biochemical process for maintaining the connective tissue of higher organisms. Severe diseases such as scurvy can result from defects in this hydroxylation, e.g., mutations in the enzyme prolyl hydroxylase or lack of the necessary ascorbate (vitamin C) cofactor.
Sources: en.wikipedia.org
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.
Mass spectrometry gives the molecular mass, which is compared with the calculated value. Reversed-phase liquid chromatography shows purity and the presence of related impurities. Peptide mapping can verify the amino acid sequence when a higher level of detail is needed.
It reports the tests the supplier performed, which may vary between laboratories and lots. Methods and acceptance criteria are not standardised across suppliers. Buyers often request the actual chromatograms and spectra rather than a summary statement.